TruGenomix Health is Leveraging Genomics to Battle Post Traumatic Stress Disorder
Project to focus on genetic testing technologies to expand access to personalized medicine
By: Phil Febbo, M.D., Chief Medical Officer of Illumina
Empowering the capabilities of Illumina’s smallest sequencer in the Democratic Republic of the Congo
The First In Vitro Diagnostic Registered Instrument for Illumina Japan
| Date | Publication | Title |
|---|---|---|
| Nov 1, 2018 | Reuters | Illumina to buy rival Pacific Biosciences in $1.2 billion deal |
| Nov 1, 2018 | CNBC | DNA sequencing giant Illumina just bought rival Pac Bio for $1.2 billion — here's why |
| Nov 1, 2018 | Forbes | DNA Sequencing Giant Illumina Will Buy Pacific Biosciences For $1.2 Billion – Exclusive CEO Interview |
| Aug 6, 2018 | CNBC | Illumina CEO on the growth of DNA sequencing |
| Jul 20, 2018 | San Diego Union Tribune | Illumina continues to soar as its gene sequencers dominate the market |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.